FDA advisors back RSV vaccines from Pfizer and GSK
A US Food and Drug Administration (FDA) advisory committee has recommended both Pfizer and GSK’s RSV vaccines: with a decision from the agency expected in May.
Archives for March 2, 2023
BioNTech to create mRNA manufacturing facility and interdisciplinary research center in Israel
BioNTech and Israel's Weizmann Institute of Science have signed a Memorandum of Understanding (MoU) to partner on research on cancer, infectious disease and neurodegenerative diseases at BioNTech’s new mRNA Excellence Center. BioNTech will also create a...
Novo Nordisk to create one of its largest R&D hubs outside of Denmark
Novo Nordisk is to expand its research and development (R&D) presence in the greater Boston metro area.
Spark breaks ground on $575m gene therapy innovation center in Philadelphia
Spark Therapeutics, a Roche company, has officially started work on its US$575m gene therapy innovation center in West Philadelphia. The center is expected to be completed by 2026.